COVID-19: AstraZeneca admits manufacturing error in vaccine, results of trials affected
AstraZeneca and Oxford University on Wednesday admitted a manufacturing error while developing coronavirus COVID-19 vaccine.
Full Article
COVID-19: AstraZeneca admits manufacturing error in vaccine, results of trials affected
Zee News
0 shares
1 views
You might like
Related news coverage
NA Proactive news snapshot: Milestone Scientific, Loncor Resources, LeanLife, Genprex, BioSig Technologies UPDATE...
Proactive Investors
Milestone Scientific Inc (NYSEAMERICAN:MLSS) president Arjan Haverhals said Monday that the developer of computerized drug delivery..
-
Volunteer seeks investigation on Serum after developing complication but company is intimidating
Mid-Day
-
Coronavirus: UK expected to approve Pfizer/BioNTech vaccine this week, acquires 2mln extra doses of Moderna jab
Proactive Investors
-
SII to seek emergency use authorisation for AstraZeneca COVID-19 vaccine in 2 weeks: Adar Poonawalla
Mid-Day
-
AstraZeneca says "dosing error" resulted in boosted vaccine trial outcome, justifying claims of "90 percent effective"
NaturalNews.com
Advertisement
More coverage
Why Oxford's Covid-19 vaccine could do more for the world than other shots
Upworthy
In the days since Oxford University and AstraZeneca unveiled the results of the partnership's Phase 3 Covid-19 vaccine trials, a..
-
Narendra Modi to visit 3 vaccine centres in Ahmedabad, Pune and Hyderabad on Nov 28
Mid-Day
-
Thailand signs supply deals for AstraZeneca COVID-19 vaccine
SeattlePI.com
-
AstraZeneca mulls new coronavirus vaccine trial following results confusion
Proactive Investors
-
Oxford/AstraZeneca Covid vaccine 'dose error' explained
BBC News